Close

First Patient Dosed in Phase II Basket Trial of Taletrectinib for Solid Tumors with NTRK Fusion

Go back to First Patient Dosed in Phase II Basket Trial of Taletrectinib for Solid Tumors with NTRK Fusion
(AMEX: IVBIY) Delayed: 18.66 --0 (-0%)
Previous Close $18.66    52 Week High
Open $18.66    52 Week Low
Day High $18.66    P/E N/A 
Day Low $18.66    EPS
Volume 11,170